Can Probiotics Prevent Caries? What 46 Clinical Trials Tell Us
A Saudi-authored systematic review of 46 clinical trials asks: can probiotics reduce caries-causing bacteria? The evidence shows a clear signal for mutans streptococci reduction — but no optimal strain, dose, or delivery vehicle yet. Here's what every Saudi dentist needs to know.
Clinical Tips
By Dr. Mahmoud H. Al-Johani
Can Probiotics Prevent Caries? What 46 Clinical Trials Tell Us
Saudi Arabia has one of the highest childhood caries burdens in the world. Approximately 96% of 6-year-olds and 93.7% of 12-year-olds experience dental caries.¹ The mean dmft in 6-year-olds ranges from 3.0 to 7.1.² Despite decades of fluoride-based prevention, the prevalence remains stubbornly high — driven by high sugar consumption, limited school-based prevention programs, and uneven access to preventive dental care.
A new systematic review and meta-analysis by Alforaidi et al. (2026), published in the Journal of Dentistry, offers the most comprehensive assessment to date of whether probiotics can meaningfully contribute to caries prevention.³ The review — co-authored by researchers from Taibah University (Medina), King Saud University (Riyadh), and King Abdulaziz University (Jeddah) — analyzed 46 randomized controlled trials and performed meta-analysis on 13 of them.
This is a chairside reality check: what the evidence supports, what it does not, and what to tell patients when they ask about probiotics for their children's teeth.
What the Review Found
Mutans Streptococci: A Clear Signal
The primary finding is that probiotic administration produces a statistically significant reduction in salivary mutans streptococci (MS) counts — the bacterial species most strongly associated with caries initiation. The meta-analysis demonstrated:
- 7 days: Effect size -0.56 (95% CI: -0.83 to -0.28)
- 14 days: Effect size -0.81
- 28 days: Effect size -0.92 (95% CI: -1.69 to -0.15)
The effect appears time-dependent — longer use produces greater reduction. This is consistent with the ecological hypothesis: probiotics compete with cariogenic bacteria for adhesion sites and nutrients, and repeated administration is needed to maintain competitive exclusion.
This finding is corroborated by two independent meta-analyses. Shi et al. (2022), pooling 43 RCTs, found salivary S. mutans declined significantly (SMD = -1.17; 95% CI: -1.85 to -0.50; p = 0.0007), while Butt et al. (2023), analyzing 17 RCTs across 3,781 preschool children, confirmed that probiotics reduce S. mutans in saliva — though notably, not in dental plaque.⁹ ˒ ¹⁰
Delivery Vehicle Matters
Yogurt, milk, and lozenges were the most effective delivery vehicles. These share a common feature: prolonged oral contact time. A lozenge dissolves slowly, delivering probiotic bacteria to the oral cavity over several minutes. Yogurt and milk coat the oral mucosa and teeth, allowing bacteria to colonize surfaces before swallowing. Delivery formats with short oral residence time (capsules, tablets swallowed whole) showed less consistent effects.
A 2026 systematic review by Rodriguez et al. specifically evaluated strain-specific effects and confirmed that L. rhamnosus SP1 and L. paracasei SD1, administered via milk or tablets for 6–10 months, significantly reduced both caries incidence and S. mutans counts.¹¹ The certainty of evidence was moderate for primary prevention and low for secondary outcomes (GRADE/ConQual).
Lactobacillus: A Double-Edged Finding
The review found that probiotic administration increased Lactobacillus spp. counts significantly at 1 month (0.43; 95% CI: 0.10 to 0.75) but not at 2 weeks. This requires careful interpretation. Lactobacillus species are used as probiotic organisms — but they are also associated with caries progression in acidic biofilm environments, particularly in deep dentinal lesions.⁴ An increase in oral lactobacilli is not inherently beneficial; it depends on the species, the pH of the microenvironment, and whether the lactobacilli are replacing more cariogenic organisms or adding to the acidogenic load.
The Shi et al. (2022) meta-analysis confirmed this paradox: Lactobacillus counts were significantly upregulated (SMD = 1.19; 95% CI: 0.46–1.92; p = 0.001), while no significant effects on total bacteria counts or salivary pH were observed.¹⁰
No Effect on Salivary Buffering
Probiotics did not produce a significant change in salivary buffer capacity. This is expected: salivary buffering is primarily determined by bicarbonate concentration and flow rate, neither of which is directly influenced by oral bacteria supplementation.
No Clear Dose-Response
Daily doses ranged from 10⁶ to 10¹⁰ CFU, and the review found no clear dose-response relationship. More is not demonstrably better. This is a practical limitation: clinicians cannot point to a specific dose and say it is evidence-based.
How Probiotics Work Against Cariogenic Bacteria
The proposed mechanisms are ecological:
Competitive exclusion. Probiotic bacteria — primarily Lactobacillus and Bifidobacterium species — compete with S. mutans for adhesion receptors on the tooth surface and for nutrients in the biofilm.
Bacteriocin production. Some probiotic strains produce bacteriocins — antimicrobial peptides that directly inhibit S. mutans growth. S. salivarius strains K12 and M18, for instance, produce bacteriocins that suppress S. mutans viability and prevent biofilm formation.⁵ Begić et al. (2023) demonstrated that S. salivarius K12, when introduced in the early stages of biofilm development, reduced the proportion of S. mutans and inhibited microcolony formation, disrupting the three-dimensional biofilm architecture.¹²
pH modulation. Some probiotics produce acids that lower the biofilm pH — but the net effect depends on whether this acidogenic activity is less harmful than the acid produced by S. mutans. The ecological balance, not the absolute presence of acid-producing bacteria, determines caries risk.
Immune modulation. Emerging evidence suggests that probiotics may influence the host immune response in the oral mucosa, though this mechanism is less well characterized for caries specifically than for periodontal disease.⁶
The Saudi Context: Why This Matters
The Caries Burden
Saudi Arabia's childhood caries prevalence is among the highest globally. The Ministry of Health reports that approximately 96% of 6-year-olds have caries experience.¹ A 2025 study found an overall prevalence of 90.8% in school children, with 86.1% having untreated decay.² The 10–12 age group showed the highest prevalence at 91.7%.
A 2025 cross-sectional study from Jeddah (Basha et al.) examining 773 children found that children with special needs had 2.87 times higher caries risk, frequent sugar consumers had 2.03 times higher risk, and obese children had 2.15 times higher risk compared to normal-weight children.¹³ The same study found that children using non-fluoridated toothpaste had 1.92 times higher caries risk — a reminder that basic prevention remains inconsistent.
These figures have not meaningfully improved despite decades of fluoride toothpaste availability. The reasons are structural: high per-capita sugar consumption, limited school-based sealant programs, inconsistent community water fluoridation, and a dental workforce distribution that favors urban centers. The TOPS trial (Almutairi et al., 2024) is currently evaluating supervised toothbrushing in Riyadh kindergartens — but results are not yet available.¹⁴
The Diabetes Connection
Saudi Arabia has one of the highest diabetes prevalence rates in the world (17.7% of adults). For diabetic children, the caries risk is compounded by xerostomia and altered salivary composition. Lai et al. (2020) demonstrated that L. brevis CD2 lozenges, administered over 60 days to type 1 diabetic children (ages 4–14), reduced S. mutans density from 3.11 to 1.82 (p < 0.01) and improved plaque pH from 5.37 to 5.49 (p < 0.01).¹⁵ This is a population where probiotics may offer particular adjunctive value — and where the evidence base is still developing.
The Dentist Knowledge Gap
A 2023 study from Alkharj found that while 96.5% of Saudi dentists were aware of the term probiotics, only 7.9% had advised patients about probiotics for oral health.⁷ 76.2% reported using probiotics therapeutically — but overwhelmingly for gastrointestinal reasons, not oral health. 81.7% expressed willingness to use probiotics for oral disease prevention.
This is a knowledge translation gap, not an awareness gap. Saudi dentists are open to probiotics — but they lack evidence-based guidance on which strains, doses, and delivery vehicles to recommend.
The Market Signal
Saudi Arabia's oral health probiotics market was valued at USD 465 million in 2025 and is projected to reach USD 1.1 billion by 2031, growing at 16.8% CAGR.⁸ Parents and patients are buying these products. The clinical question is whether the evidence supports the market.
What to Tell Patients
For Parents of High-Caries-Risk Children
Probiotics may be a useful adjunct for children with:
- High S. mutans counts
- Active caries despite fluoride exposure
- Dietary patterns high in fermentable carbohydrates
- Orthodontic appliances that increase plaque retention
- Type 1 diabetes (based on Lai et al. evidence)¹⁵
The evidence supports 2–4 weeks of daily use to achieve meaningful MS reduction. Lozenges, yogurt, or milk-based delivery are preferred over swallowed capsules. Beyond 4 weeks, the data thin out — and the review could not identify an optimal long-term protocol.
Probiotics are not a replacement for fluoride, sealants, or mechanical plaque control. The review is explicit on this point. The clinical significance statement reads: probiotics should complement, not replace, established preventive strategies.
For General Dental Practitioners
- There is no evidence-based optimal strain, dose, or delivery vehicle. The review could not recommend a specific protocol.
- The Lactobacillus count increase at 1 month should be monitored. If using a Lactobacillus-based probiotic, the net effect on the cariogenic load should be assessed clinically, not assumed.
- Probiotics are best positioned as a time-limited intervention — a 4-week course during a high-risk period (e.g., after caries treatment, during orthodontic adjustment) rather than indefinite daily use.
- Document the recommendation, the strain, the dose, and the rationale. This is an emerging field — clinical records should reflect what was recommended and why.
What the Evidence Does Not Yet Tell Us
This is a mature systematic review with a careful meta-analysis, but the heterogeneity across the 46 studies is substantial. The studies varied in:
- Strains used (at least 12 different species across the included trials)
- Doses (4 orders of magnitude range)
- Delivery vehicles (yogurt, milk, lozenges, tablets, drops, cheese, capsules)
- Populations (children vs. adults, varying baseline caries risk)
- Outcome measures and follow-up durations
The review authors explicitly state that this heterogeneity prevents identification of a clearly superior vehicle, dose, or strain. This is honest and important. The evidence supports the concept — probiotics reduce MS counts — but does not yet support a specific clinical protocol.
Long-term caries incidence data (actual cavitated lesions, not just bacterial counts) remain limited. MS reduction is a surrogate endpoint. The translation from fewer S. mutans to fewer cavities over years of follow-up is the question that still needs answering.
A 2025 pilot RCT by Starck et al. illustrates the challenge: 40 children received multi-strain probiotic lozenges for 30 days, and while trends toward higher salivary pH, improved buffering, and reduced S. mutans were observed, no parameter reached statistical significance.¹⁶ Short-term studies with small samples may miss effects that require longer colonization periods to manifest.
Key Takeaways
1. Probiotics produce a statistically significant, time-dependent reduction in salivary mutans streptococci — the primary caries-initiating bacteria — with the strongest effect at 28 days of use.
2. Yogurt, milk, and lozenges are the most effective delivery vehicles, likely due to prolonged oral contact time. Capsules and swallowed tablets are less effective.
3. No optimal strain, dose, or delivery vehicle can yet be recommended with confidence. Doses from 10⁶ to 10¹⁰ CFU showed no clear dose-response. However, L. rhamnosus SP1 and L. paracasei SD1 show the strongest strain-specific evidence.
4. Probiotics increase Lactobacillus counts — a finding that requires caution, as lactobacilli contribute to caries progression in acidic environments.
5. Probiotics should complement, not replace, fluoride, sealants, and mechanical plaque control. The evidence does not support probiotics as a standalone preventive strategy.
6. Saudi dentists are aware of probiotics (96.5%) but rarely recommend them for oral health (7.9%). The knowledge translation gap is the immediate barrier — not awareness.
7. Saudi Arabia's oral health probiotics market is growing at 16.8% annually. The evidence supports cautious optimism but not yet the market's enthusiasm.
8. For diabetic children — a high-risk population in Saudi Arabia — L. brevis CD2 lozenges show promising preliminary evidence for reducing cariogenic bacteria.
References
1. Ministry of Health, Kingdom of Saudi Arabia. Oral health surveillance data. Cited in: Al-Banyan A, et al. Prevalence and clinical risk factors of dental caries in Saudi Arabia. Sci Rep. 2025. doi:10.1038/s41598-025-95534-5
2. Al-Malik MI, Rehbini Y. Prevalence of dental caries, severity, and pattern in age 6 Saudi children. J Contemp Dent Pract. 2006;7(2):46-53. Also: AlAgili DE. A systematic review of population-based dental caries studies in Saudi Arabia. Saudi Dent J. 2013. doi:10.1016/j.sdentj.2012.10.002
3. Alforaidi S, Cirio S, Cagetti MG, Almosa N, Zafar H, Ashi H, Campus G, Lingström P. Effect of probiotics duration, delivery vehicle, and dose on caries-related variables: A systematic review and meta-analysis. J Dent. 2026;107008. doi:10.1016/j.jdent.2026.107008. PMID: 42660271.
4. Marsh PD. Dental plaque as a biofilm and a microbial community — implications for health and disease. BMC Oral Health. 2006;6 Suppl 1:S14. doi:10.1186/1472-6831-6-S1-S14
5. TW, Hardie JM, Homer KA. Antimicrobial effect of probiotic bacteriocins on oral pathogens. Front Cell Infect Microbiol. 2024. PMID: 38288293
6. Stamatova I, Meurman JH. Probiotics and periodontal disease: a review. Swiss Dent J. 2008;118(5):418-423.
7. Gowdar IM, Aljuma A, Alenazi N, et al. Knowledge and attitude of dental practitioners about probiotics in Alkharj, Kingdom of Saudi Arabia. J Pharm Bioallied Sci. 2023;15(Suppl 1):S350-S353. PMID: 37654333
8. Ken Research. Saudi Arabia Oral Health Probiotics Market Report. 2025. Market valuation data.
9. Butt S, et al. Can probiotics prevent dental caries? Evidence-Based Dentistry. 2023. doi:10.1038/s41432-023-00918-z
10. Shi J, et al. Efficacy of probiotics against dental caries in children: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022. doi:10.1080/10408398.2022.2077693
11. Rodriguez G, et al. Probiotic supplementation and dental caries prevention in children and adolescents: a systematic review of strain-specific and context-dependent effects. Clin Oral Investig. 2026. doi:10.1007/s00784-026-06752-8
12. Begić G, et al. Streptococcus salivarius as an important factor in dental biofilm homeostasis: influence on Streptococcus mutans and Aggregatibacter actinomycetemcomitans in mixed biofilm. Int J Mol Sci. 2023;24(8):7249. doi:10.3390/ijms24087249
13. Basha S, et al. Association between dental caries prevalence and body mass index in children with and without special needs: a comparative study in Jeddah, Saudi Arabia. J Clin Med. 2025;14(12):4165. doi:10.3390/jcm14124165
14. Almutairi B, et al. Toothbrushing programme in Saudi Arabia "TOPS": a study protocol for a cluster randomised controlled trial in kindergartens, Riyadh. BMJ Open. 2024. doi:10.1136/bmjopen-2023-083504
15. Lai S, et al. Effect of Lactobacillus brevis CD2 containing lozenges on plaque pH and cariogenic bacteria in diabetic children: a randomised clinical trial. Clin Oral Investig. 2020. doi:10.1007/s00784-020-03342-0
16. Starck E, et al. Effects of probiotic short-term regiment on oral health parameters in children: a pilot randomized controlled trial. Nutrients. 2025;17(22):3604. doi:10.3390/nu17223604